Comment
doi: 10.1001/jamaoncol.2017.0342.
Multigene Panel Testing and Breast Cancer Risk: Is It Time to Scale Down?
Affiliations
- PMID: 28418452
- DOI: 10.1001/jamaoncol.2017.0342
Item in Clipboard
Comment
Multigene Panel Testing and Breast Cancer Risk: Is It Time to Scale Down?
JAMA Oncol.
.
No abstract available
Comment on
-
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.JAMA Oncol. 2017 Sep 1;3(9):1190-1196. doi: 10.1001/jamaoncol.2017.0424. JAMA Oncol. 2017. PMID: 28418444 Free PMC article.
Similar articles
-
Impact of Multigene Panel Testing on Surgical Decision Making in Breast Cancer Patients.J Am Coll Surg. 2018 Apr;226(4):560-565. doi: 10.1016/j.jamcollsurg.2017.12.037. Epub 2018 Jan 31. J Am Coll Surg. 2018. PMID: 29360614
-
Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.JAMA Oncol. 2015 Oct;1(7):943-51. doi: 10.1001/jamaoncol.2015.2690. JAMA Oncol. 2015. PMID: 26270727
-
Development and testing of the KnowGene scale to assess general cancer genetic knowledge related to multigene panel testing.Patient Educ Couns. 2019 Aug;102(8):1558-1564. doi: 10.1016/j.pec.2019.04.014. Epub 2019 Apr 13. Patient Educ Couns. 2019. PMID: 31010603
-
"Decoding hereditary breast cancer" benefits and questions from multigene panel testing.Breast. 2019 Jun;45:29-35. doi: 10.1016/j.breast.2019.01.002. Epub 2019 Jan 8. Breast. 2019. PMID: 30822622 Review.
-
Genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.Expert Rev Anticancer Ther. 2015;15(11):1315-26. doi: 10.1586/14737140.2015.1090879. Epub 2015 Nov 2. Expert Rev Anticancer Ther. 2015. PMID: 26523341 Review.
Cited by
-
Integrative genomic analysis implicates ERCC6 and its interaction with ERCC8 in susceptibility to breast cancer.Sci Rep. 2020 Dec 4;10(1):21276. doi: 10.1038/s41598-020-77037-7. Sci Rep. 2020. PMID: 33277540 Free PMC article.
-
Implication and Influence of Multigene Panel Testing with Genetic Counseling in Korean Patients with BRCA1/2 Mutation-Negative Breast Cancer.Cancer Res Treat. 2022 Oct;54(4):1099-1110. doi: 10.4143/crt.2021.978. Epub 2021 Nov 17. Cancer Res Treat. 2022. PMID: 34793666 Free PMC article.
-
Determination of thresholds of risk in women at average risk of breast cancer to personalize the organized screening program.Sci Rep. 2021 Sep 27;11(1):19104. doi: 10.1038/s41598-021-98604-6. Sci Rep. 2021. PMID: 34580360 Free PMC article.
-
Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary Cancers.JCO Precis Oncol. 2020 Aug 19;4:PO.19.00301. doi: 10.1200/PO.19.00301. eCollection 2020. JCO Precis Oncol. 2020. PMID: 32954205 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
